Why brain health is becoming one of the most important health conversations of our time

A memory can appear to be a small thing.

The name of a familiar place. A conversation with a loved one. The route home. The face of someone who has been part of our lives for decades.

Together, however, these memories form something far greater: our identity, our relationships and our sense of place in the world.

This is what makes Alzheimer's disease so difficult: a progressive neurodegenerative disease that affects far more than memory — a person's independence, relationships and the future they had imagined for themselves and their family.

And no one experiences Alzheimer’s alone. Behind every person living with the disease is often a family learning to navigate an unfamiliar and deeply emotional journey.

Rethinking what it means to age well

Across the UAE and Gulf, people are living longer, health systems are evolving, and governments are investing in prevention, innovation and quality of life.

Living longer is a remarkable achievement, but longevity alone cannot be the final measure of success — those extra years should be lived, as far as possible, with cognitive health, dignity, independence and meaningful human connection.

Yet conversations about the brain remain difficult. We need an environment where people don’t treat every moment of forgetfulness as a sign of disease but giving brain health the same thoughtful attention we give other aspects of our wellbeing.

Science is changing the conversation

For years, Alzheimer’s disease was discussed with an overwhelming sense of inevitability. Today, advances in science are deepening our understanding of how the disease develops and how it may be detected and managed — shifting the conversation towards recognizing concerns, seeking medical advice and reaching an accurate diagnosis as early as possible.

This progress brings hope—but also responsibility. Its full value depends on healthcare systems ready to deliver it: clear assessment and referral pathways, diagnostic and specialist capacity, and families and caregivers who know where to find reliable support. That will require collaboration among governments, healthcare providers, researchers, patient communities and industry—not one organization alone.

Why Lilly is committed to neuroscience for the long term

At Lilly, we understand both the promise and the difficulty of neuroscience. We have pursued Alzheimer’s research for more than 35 years—through advances, setbacks and unanswered questions—and that experience has taught us progress rarely follows a straight line. Some of the most complex challenges in medicine are also the ones most worth confronting.

An opportunity for the UAE and Gulf

The UAE and Gulf have an opportunity to help shape this emerging chapter in brain health. The region has repeatedly demonstrated what can be achieved when national ambition, healthcare investment, scientific expertise and partnership come together—and that same energy can help build a more brain-health-ready society.

This means increasing public understanding while approaching Alzheimer’s with cultural sensitivity, and strengthening connections among primary care, specialists, diagnostic services and caregiver support.

It also means connecting brain health to the region’s own longevity ambitions—from Abu Dhabi’s Longevity-First Health Ecosystem, advancing precision medicine, prevention and citizen empowerment, to the Dubai Longevity Authority’s work linking research, innovation and investment—so cognitive health has a natural place within this broader vision of healthy ageing.

Family and community are central to the social fabric of the Gulf, and these bonds should not have to carry the journey alone; they need information, understanding and systems that support them throughout.

Alzheimer’s Awareness Month is a platform to speak more openly about the disease—but awareness must be the beginning, not the endpoint. The next step is to translate it into action: more informed conversations, stronger support for families, clearer healthcare pathways and continued investment in the science that can transform what may be possible.